Healthcare Services Singapore

Singapore Bioanalytical Testing Services Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Singapore Bioanalytical Testing Services Market Industry Trends and Forecast to 2034: Segmented by (Test, Molecule, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $7.5 Mn Placeholder estimate
Estimate 2025 $8.4 Mn 0.1% of the global market
Projected 2034 $21.4 Mn 155.8% Adds $13.1 Mn over 9 forecast years
CAGR 2025–2034 11.0% Faster than 63% of 107 Healthcare Services markets here
Key players 5
  • Singapore is 0.14% of the global market.
  • In APAC, the largest is China at $435.0 Mn.
  • Fastest growing: India at 12.8% a year.
  • Singapore ranks 9th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$13.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Bioanalytical Testing Services Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $7.5 Mn — —
2025 (base) $8.4 Mn +$0.8 Mn —
2026 (forecast) $9.3 Mn +$0.9 Mn +11%
2027 (forecast) $10.3 Mn +$1.0 Mn +23.2%
2028 (forecast) $11.5 Mn +$1.1 Mn +36.8%
2029 (forecast) $12.7 Mn +$1.3 Mn +51.8%
2030 (forecast) $14.1 Mn +$1.4 Mn +68.5%
2031 (forecast) $15.7 Mn +$1.6 Mn +87%
2032 (forecast) $17.4 Mn +$1.7 Mn +107.6%
2033 (forecast) $19.3 Mn +$1.9 Mn +130.5%
2034 (forecast) $21.4 Mn +$2.1 Mn +155.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $6.05 Bn
  2. North America $3.28 Bn
  3. US $2.66 Bn
  4. APAC $1.25 Bn
  5. Europe $1.03 Bn
  6. Canada $520.6 Mn
  7. China $435.0 Mn
  8. Japan $361.9 Mn
  9. Latin America $307.1 Mn
  10. Germany $216.9 Mn
  11. Middle East $215.1 Mn
  12. France $170.5 Mn
  13. Brazil $158.7 Mn
  14. UK $147.3 Mn
  15. Italy $129.5 Mn
  16. Spain $104.3 Mn
  17. Ecuador $104.8 Mn
  18. India $107.4 Mn
  19. Africa $100.4 Mn
  20. Saudi Arabia $99.0 Mn
  21. Mexico $80.4 Mn
  22. Australia $70.5 Mn
  23. Russia $59.2 Mn
  24. New Zealand $57.0 Mn
  25. South Africa $39.0 Mn
  26. UAE $27.2 Mn
  27. Egypt $18.9 Mn
  28. Philippines $15.3 Mn
  29. Malaysia $8.6 Mn
  30. Hong Kong $8.4 Mn
  31. Singapore (this report) $8.4 Mn
  32. Thailand $6.9 Mn
  33. Kenya $4.3 Mn

Report snapshot

Singapore Bioanalytical Testing Services Market Analysis at a glance
Market size, 2025$8.4 Mn placeholder estimate
Forecast, 2034$21.4 Mn placeholder estimate
Growth (CAGR), 2025–203411.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, molecule and end user (see all)
Key playersLabcorp, Charles River Laboratories, ICON Plc, Eurofins Scientific, Frontage Laboratories (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Singapore Bioanalytical Testing Services Market Analysis Executive Summary

Bioanalytical testing services measure drugs and biomarkers in samples from studies to show how medicines behave in the body.

Key segments of the bioanalytical Testing Services market include test (Pharmacokinetics, Immunogenicity and Biomarkers) and molecule (Small Molecules, Biologics and Cell and Gene Therapies).

Bar chart: Singapore Bioanalytical Testing Services market size, 2024–2034, placeholder estimates. $7.5 Mn in 2024, $8.4 Mn in 2025 and $21.4 Mn in 2034, 11.0% CAGR.
Singapore Bioanalytical Testing Services market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Singapore Bioanalytical Testing Services Market Dynamics

Market Growth Drivers

Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the bioanalytical Testing Services market. Many companies now outsource work they used to do in-house.

Opportunity

Advanced therapies, AI-driven operations and expansion in India, China and Southeast Asia give the bioanalytical Testing Services market room to grow.

Market Restraints

Capacity shortages, strict quality rules, data security concerns and pricing pressure hold back the bioanalytical Testing Services market.

Competitive Landscape for Bioanalytical Testing Services Market in Singapore

The bioanalytical Testing Services market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Bioanalytical Testing Services Market in Singapore

Bioanalytical Testing Services in Singapore: payment

MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.⁠[1]

[1] CPF Board, MediShield Life. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how bioanalytical Testing Services services are delivered and paid for in Singapore. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Bioanalytical Testing Services right now, from free public sources.

Latest research 1,993 papers since 2021 (worldwide)

  1. A new high-performance electrochemical sensor fabricated by metal-organic framework/Ketjen black composite for sensitive detection of chlorogenic acid in food and blood serum. Journal of colloid and interface science, 2026
  2. Micro-flow LC- drift tube IMS-MS with high-resolution demultiplexing for enhanced lipidome coverage of volume-limited biological samples. Talanta, 2026
  3. Development of a Rapid and Simple LC-MS/MS Method for the Quantitation of Baricitinib in Human Plasma and Aqueous Humor. Journal of mass spectrometry and advances in the clinical lab, 2026
  4. A novel type V natural deep eutectic solvent with built-in pH-regulation for magnetic dispersive liquid-liquid microextraction of central nervous system drugs in plasma samples. Frontiers in chemistry, 2026
  5. LC-MS determination of dopaminergic catecholamines in tissues and biofluids using streamlined sample preparation and heterocyclic NHS-ester derivatization. Analytical and bioanalytical chemistry, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Bioanalytical Testing Services in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 7th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Bioanalytical Testing Services market in Singapore?
Placeholder estimate: about $8.4 Mn in 2025, rising to about $21.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Bioanalytical Testing Services market in Singapore growing?
Placeholder estimate: about 11.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Bioanalytical Testing Services market report cover?
The report splits the market by test (Pharmacokinetics, Immunogenicity, Biomarkers, Bioequivalence), molecule (Small Molecules, Biologics, Cell and Gene Therapies) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Bioanalytical Testing Services market?
Key players include Labcorp, Charles River Laboratories, ICON Plc, Eurofins Scientific and Frontage Laboratories.
What is driving the Bioanalytical Testing Services market?
Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the bioanalytical Testing Services market. Many companies now outsource work they used to do in-house.
How is healthcare paid for in Singapore?
MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts. Source: CPF Board, MediShield Life. Checked 14 Nov 2026.
How much research is published on Bioanalytical Testing Services?
PubMed lists 1,993 papers on Bioanalytical Testing Services added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Bioanalytical Testing Services in Singapore? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Bioinformatics: Making Sense of Health DataSequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics… Decentralized Clinical Trials: Bringing Trials to PatientsIn September 2024 the FDA finalised guidance on trials with decentralised elements, such as telehealth… Digital Biomarkers: The Next Vital SignsPhones and wearables can measure how people walk, talk, sleep and move. These digital biomarkers are starting…
Back to Catalogue
Keep exploring

Related Healthcare Services reports in Singapore

See all
Same topic, other categories

Related on drug development and manufacturing and clinical trials

See the topic